KLSC is a life sciences investment company fully owned by the Kuwait Investment Authority and National Technology Enterprises Company. It aims to advance healthcare in Kuwait and the Gulf region by investing in innovative companies and technologies, and establishing the first healthcare academy in the GCC to provide education and training. KLSC has investments in companies like Newbridge Pharmaceuticals and Clinart MENA that are addressing unmet medical needs, and works with partners around the world in areas like medical technology, diagnostics and pharmaceuticals.
Over the last 8 years Scotland has made a very significant investment in building the human and physical infrastructure required to leverage our leading position in the field of stem cell biology to support the development of a thriving Scottish Regenerative Medicine industrial sector. This initial investment is nearing completion, has substantially delivered and has started to make a real impact. However its full value will only be realised as the world-wide regenerative medicine sector matures and near term scientific, technical and industrial impediments are overcome. Our competitors in other parts of the UK and across the world are continuing to invest in this space in order to imbue their nascent industries with comparative advantage.
With these considerations in mind the community has undertaken a review of the current state of play, in order to determine what now needs to be done in order to drive the growth of the Regenerative Medicine industry in Scotland and embed significant long-term benefits to the economy and health of the nation.
This document sets out a strategy which has been developed in collaboration with the academic, business and clinical communities. It is intended for high-level discussion and to provide a framework for future collective direction and investment.
The Celtic Advanced Life Science Innovation Network
(CALIN) is a 4-year Ireland-Wales INTERREG operation
funded by the European Regional Development Fund
through the Ireland Wales Territorial programme.
CALIN connects businesses with world-leading Higher
Education Institutions to advance life science product and
service development.
KHABEER is an organization that provides technological infrastructure that healthcare organizations need to succeed in the 21st century knowledge economy to be recognized as a center of excellence.
Vision:
To change the type of the information collected and it’s method of use globally through our innovative, exceptional, world class healthcare solutions & technologies.
We are committed to being the premier, research-intensive Health Information Technology Company and are dedicated to providing leading innovations and solutions for today and the future.
Mission:
To discover, develop and deliver innovative, exceptional, world class healthcare solutions & technologies that save and improve lives around the world.
Values:
Our core values are driven by a desire to improve life, achieve medical & technological excellence, operate with:
Courage.
Achievement.
Responsibility.
Teamwork.
Knowledge transfer.
Innovation.
Integrity.
As of my last knowledge update in September 2021, the list of the top Contract Research Organizations (CROs) can vary depending on factors such as revenue, services offered, therapeutic areas of expertise, and global presence. The following list includes some of the prominent CROs based on their reputation, scale, and contributions to the clinical research industry:
IQVIA (formerly QuintilesIMS):
IQVIA is one of the largest CROs in the world, offering a wide range of services including clinical development, real-world evidence solutions, commercialization services, and consulting. They have a vast global network and expertise across various therapeutic areas.
PPD (Pharmaceutical Product Development):
PPD is known for its comprehensive clinical trial services, laboratory services, and real-world evidence solutions. They have a strong global presence and experience in managing trials of varying complexity.
Covance:
Covance, a subsidiary of LabCorp, is known for its extensive portfolio of drug development services including clinical development, central laboratory services, and market access solutions. They have experience in a broad range of therapeutic areas.
Syneos Health:
Syneos Health offers integrated solutions across clinical development, commercialization, and real-world evidence. They focus on helping clients navigate the entire drug development journey.
ICON:
ICON provides a variety of clinical research services, including consulting, clinical trial execution, laboratory services, and outcomes research. They have expertise in a wide array of therapeutic areas.
Parexel:
Parexel offers services ranging from clinical research and regulatory consulting to market access and commercialization. They are known for their global reach and innovative approach to clinical trials.
WuXi AppTec:
WuXi AppTec is a global company that provides a wide range of R&D services, including preclinical and clinical development, manufacturing, and regulatory services.
Medpace:
Medpace is known for its focused and customized approach to clinical trial management, particularly in the area of complex and specialized studies.
Celerion:
Celerion specializes in early-stage clinical research, with a focus on providing solutions for both small and large molecules.
Charles River Laboratories:
While Charles River Laboratories primarily focuses on preclinical research, they also offer a range of early-stage clinical development services.
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
The 10 Best Performing CEOs to Watch in 2020.” This issue focuses on some best performing CEOs out there who have made a significant mark in the industry.
The 10 best performing ce os to watch in 2020Merry D'souza
Benoit came on board with the strong conviction that the concentration in the Contract Research Organization (“CRO”) market left broad open incredible opportunities to companies capable of showing superior agility than multinational CRO giants whose size and overheads are a handicap for turnaround time optimization purposes.
John O'Halloran, Solid State Pharmaceutical ClusterInvestnet
Solid State Pharmaceutical Cluster (SSPC) - Enabling Innovation in Pharma. Presentation Video http://www.youtube.com/watch?v=S8BlZ8eqA94&list=UUrqilkHGkk9VlP1V1J8o-Og&index=6&feature=plcp
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Over the last 8 years Scotland has made a very significant investment in building the human and physical infrastructure required to leverage our leading position in the field of stem cell biology to support the development of a thriving Scottish Regenerative Medicine industrial sector. This initial investment is nearing completion, has substantially delivered and has started to make a real impact. However its full value will only be realised as the world-wide regenerative medicine sector matures and near term scientific, technical and industrial impediments are overcome. Our competitors in other parts of the UK and across the world are continuing to invest in this space in order to imbue their nascent industries with comparative advantage.
With these considerations in mind the community has undertaken a review of the current state of play, in order to determine what now needs to be done in order to drive the growth of the Regenerative Medicine industry in Scotland and embed significant long-term benefits to the economy and health of the nation.
This document sets out a strategy which has been developed in collaboration with the academic, business and clinical communities. It is intended for high-level discussion and to provide a framework for future collective direction and investment.
The Celtic Advanced Life Science Innovation Network
(CALIN) is a 4-year Ireland-Wales INTERREG operation
funded by the European Regional Development Fund
through the Ireland Wales Territorial programme.
CALIN connects businesses with world-leading Higher
Education Institutions to advance life science product and
service development.
KHABEER is an organization that provides technological infrastructure that healthcare organizations need to succeed in the 21st century knowledge economy to be recognized as a center of excellence.
Vision:
To change the type of the information collected and it’s method of use globally through our innovative, exceptional, world class healthcare solutions & technologies.
We are committed to being the premier, research-intensive Health Information Technology Company and are dedicated to providing leading innovations and solutions for today and the future.
Mission:
To discover, develop and deliver innovative, exceptional, world class healthcare solutions & technologies that save and improve lives around the world.
Values:
Our core values are driven by a desire to improve life, achieve medical & technological excellence, operate with:
Courage.
Achievement.
Responsibility.
Teamwork.
Knowledge transfer.
Innovation.
Integrity.
As of my last knowledge update in September 2021, the list of the top Contract Research Organizations (CROs) can vary depending on factors such as revenue, services offered, therapeutic areas of expertise, and global presence. The following list includes some of the prominent CROs based on their reputation, scale, and contributions to the clinical research industry:
IQVIA (formerly QuintilesIMS):
IQVIA is one of the largest CROs in the world, offering a wide range of services including clinical development, real-world evidence solutions, commercialization services, and consulting. They have a vast global network and expertise across various therapeutic areas.
PPD (Pharmaceutical Product Development):
PPD is known for its comprehensive clinical trial services, laboratory services, and real-world evidence solutions. They have a strong global presence and experience in managing trials of varying complexity.
Covance:
Covance, a subsidiary of LabCorp, is known for its extensive portfolio of drug development services including clinical development, central laboratory services, and market access solutions. They have experience in a broad range of therapeutic areas.
Syneos Health:
Syneos Health offers integrated solutions across clinical development, commercialization, and real-world evidence. They focus on helping clients navigate the entire drug development journey.
ICON:
ICON provides a variety of clinical research services, including consulting, clinical trial execution, laboratory services, and outcomes research. They have expertise in a wide array of therapeutic areas.
Parexel:
Parexel offers services ranging from clinical research and regulatory consulting to market access and commercialization. They are known for their global reach and innovative approach to clinical trials.
WuXi AppTec:
WuXi AppTec is a global company that provides a wide range of R&D services, including preclinical and clinical development, manufacturing, and regulatory services.
Medpace:
Medpace is known for its focused and customized approach to clinical trial management, particularly in the area of complex and specialized studies.
Celerion:
Celerion specializes in early-stage clinical research, with a focus on providing solutions for both small and large molecules.
Charles River Laboratories:
While Charles River Laboratories primarily focuses on preclinical research, they also offer a range of early-stage clinical development services.
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
The 10 Best Performing CEOs to Watch in 2020.” This issue focuses on some best performing CEOs out there who have made a significant mark in the industry.
The 10 best performing ce os to watch in 2020Merry D'souza
Benoit came on board with the strong conviction that the concentration in the Contract Research Organization (“CRO”) market left broad open incredible opportunities to companies capable of showing superior agility than multinational CRO giants whose size and overheads are a handicap for turnaround time optimization purposes.
John O'Halloran, Solid State Pharmaceutical ClusterInvestnet
Solid State Pharmaceutical Cluster (SSPC) - Enabling Innovation in Pharma. Presentation Video http://www.youtube.com/watch?v=S8BlZ8eqA94&list=UUrqilkHGkk9VlP1V1J8o-Og&index=6&feature=plcp
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
3. CEO’S MESSAGE
Aspirations 7
INTRODUCTION
Birth 9
ROAD MAP
Code 11
Path 11
Secret 13
BUSINESS FOCUS
Investments 15
Newbridge pharmceuticals 17
Contents
Clinart 19
Orzone 21
Medical Technologies 23
Life Science Academy 25
CONTACT 27
4. CEO’S MESSAGE
ASPIRATIONS
“ The Gulf region and greater Middle East
is currently ripe for opportunities and
potential growth, but with challenges.
KLSC is uniquely positioned to help
various regional and international
companies capture lucrative
opportunities, accommodate the
inherent challenges and reap the great
“
rewards that come with them
Qais Marafie
Chief Executive Officer
7
5. Introduction
Birth
• Kuwait Life Sciences Company is fully owned by Kuwait Investment
Authority (KIA) and its subsidiary National Technology Enterprises Company
(NTEC). KLSC is capitalized at 9 million Kuwaiti Dinars. KLSC supports both
public and private sectors to access emerging technologies and adopt best
practices prevailing in today’s healthcare systems
• Kuwait Life Sciences Company is fully owned by National Technology
Enterprises Company (NTEC). KLSC supports both public and private sectors
to access emerging technologies and adopt best practices prevailing in
today’s healthcare systems
• NTEC which was established in 2004 by ‘Kuwait Council of Ministers’, fully
owned by the Kuwait Investment Authority (KIA) and mandated to transfer
technology and know-how to Kuwait by creating and investing in projects
with advanced technologies
9
6. Road Map
Code
• To engage in a unique role of developing and advancing the local & regional
healthcare systems and services
• To accelerate the transfer of best in-class technologies and innovative
business models practiced globally to match the needs and demands of
Kuwait & the Gulf region
• To present healthcare professionals with distinguished opportunities for
development and growth in synchronization with international standards
and modern practices
Path
• KLSC integrates unique solutions for unmet medical need
• KLSC transmigrate international business opportunities and technologies
to contribute to the development of the region and enhance the skills and
capabilities of healthcare professionals and leaders
• KLSC lives among distinguished partners, capable allies, and renowned
experts to breed significant value to the life sciences industry
11
7. Road Map
Secret
• Innovation: We continue to build an internal environment of innovation
to couple unique initiatives, technologies or intellects.
• Synergy: We connect the dots and strive to Synergize ideas, concepts,
teams and projects
• Passion: We seek to hire and work with those who have passion for
excellence, differentiation, and superior performance
• Vitality: We live our day dream as a team and execute our responsibilities
with Vitality
• Integrity: We inhabit ethics in our relationships with healthcare
professionals, patients and community and processes science and education
with Integrity
13
8. Business Focus
Investments
• KLSC has a broad international network of venture capital and private
equity funds, technology transfer centers, multinational pharmaceutical
companies, and scientific experts across various life science fields. KLSC
leverages on the exposure and expertise of its parent company NTEC and
also the vast network & strengths of KIA to actively invest in innovative
companies and bright teams
• KLSC looks for opportunities from start-up projects requiring seed capital
to established businesses looking for growth capital. KLSC is a medium
to long term investor leading or co-leading regional projects in the MENA
region
• KLSC major areas of investment are in medical technology, diagnostics,
pharmaceuticals and healthcare services which address critical and prevalent
diseases
• KLSC also works actively with the its portfolio management team to
accelerate product penetration into the Gulf and Middle East, finding and
expanding the right team and the overall execution of the strategy
• KLSC has successful investments in several international companies at
early and late stage. Among which are Immatics Biotechnologies GmbH
(Germany), Oxford Immunotec (UK), StemCyte Inc. (USA), MTM Laboratories
AG. (Germany & USA), Median Technologies (France), Orzone (Sweden)
• KLSC invested in reputed life sciences funds like Wellington Partners
(Germany), Burrill & Co. (USA) , CMEA (USA). Regional Investments include:
NewBridge Pharmaceuticals and Clinart MENA
15
9. Strategic Investments
NEWBRIDGE PHARMACEUTICALS
NewBridge Pharmaceuticals (NBP), headquartered in Dubai, is a first-inclass
specialty therapeutics company focused on innovative pharmaceuticals and
biotechnological medicines.
NBP specializes in licensing, registering and commercializing FDA, EMA/
European and Japanese (PMDA) approved therapeutics, to address the unmet
medical needs of diseases with high regional prevalence in the Middle East,
Africa, Turkey and Caspian (AFMET) regions.
NewBridge focuses on products for oncology and supportive care, metabolic
disorders, gastrointestinal conditions and other specialty segments.
Planned future expansion includes establishing NBP own branded products
through the establishment of manufacturing and R&D capabilities.
www.nbpharma.com
17
10. Strategic Investments
CLINART MENA
ClinArt is a full service Contract Research Organization (CRO), headquartered
in Dubai Health Care City, which brings an international clinical research
expertise and quality services to the Middle East region in line with local
cultures and customs.
Clinart MNEA has a proven track record of successful clinical trials covering
phase II, III and phase IV; also known as post-marketing studies. The company
has strong relationships with various multinational pharmaceutical companies
which become permanent clients perceiving that Clinart is the right vendor for
the MENA region.
Clinical research awareness is among the prime objectives of Clinart & to
foster clinical research culture and infrastructure in the MENA region. ClinArt
has offices in Egypt, Saudi Arabia, and Lebanon, through which it operates in
the broader Middle East.
www.clinart.net
19
11. Strategic Investments
Orzone
Orzone is a medical training company that focus on improving medical outcome
by developing creative tools, which support training and assessments of
medical skills.
Orzone products are based on e-learning and advanced simulation technology
for individuals or teams. Orzone is committed to improve healthcare quality
and minimize the risk of medical errors by facilitating medical training.
Orzone was founded by leading industry experts. The Orzone team is an
innovative force globally and has experience from over 500 training installations
and its use in 200 published scientific peer-reviewed studies.
Orzone is based in Gothenburg, Sweden. In February 2013 the first GCC regional
office was establish in Dubai.
www.orzone.com
21
12. Business Focus
Medical Technologies
• KLSC commercializes innovative medical technologies companies which
enhance the quality and speed of diagnostics, through the retail of high
tech. medical instruments, consumables and reagents
• KLSC provides vital services aiming to combat majority of critical clinical
areas in this emerging region. Our broad range of innovative diagnostic
tests and systems play a vital role in the area of integrated healthcare
solutions and cover the early detection, targeted screening, evaluation and
monitoring of disease
• KLSC fully supports its partners and suppliers who are located worldwide
spanning over the US, Canada, central Europe and South Asia, by a
proffesional team of sales, marketing and technical support; to further
penetrate Middle Eastern countries and contribute to the advancement of
healthcare services
• Medical technologies department specializes in; laboratory diagnostics,
surgical & Imaging, mobile Health and screening programmes (Diabetes &
Cancer)
23
13. Business Focus
Life Science Academy
• KLSC established the first healthcare academy in the GCC region that
provides revolutionary knowledge, education and professional development
programs across all healthcare sectors
• Life Science Academy offers a unique platform for Continuous Professional
Development (CPD) programs and lucrative opportunity to be abreast of
international practices. The Life Science Academy aims to facilitate the
transfer of latest technologies & practices in healthcare services and
bridges the strategic gap in know-how and best practices sought by local
& regional healthcare community
• Life Science Academy functions in collaboration and affiliation of international
medical universities, reputed academies & recognized institutes whether
for profit or non-profit organizations
• Life Science Academy courses are targeted towards nurses, pharmacists,
physicians, surgeons, biomedical engineers as well as leaders & managers
across sectors of healthcare industry
25
14. Contact
Address
Kuwait Life Sciences Company
KIPCO Tower 27th floor,
Al Shohadaa Street,
Block 9, Kuwait City, Kuwait
P.O. Box 25363, Safat 13114, Kuwait
Telephone
+965 22490969 – 22479787
Fax
+965 22490959
Website
www.klsc.com.kw
27
15. Innovative Investments Advancing Healthcare
�شركة مملوكة بالكامل للوطنية مل�شاريع التكنولوجيا �ش م ك م
Fully owned by the National Technology Enterprises Company KCSC